Abraham Korman is a Dermatology physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 137 publications with 966 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
540 Officenter Pl Ste 240
Gahanna, OH 432305317
Telephone
614-293-1707Provider last certified this registry record 4 Sept 2025.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20247 payments$12,375openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
19.2%Corticosteroid10.3%Triamcinolone Acetonide77%Fluocinolone Acetonide24%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist8.9%Dupixent Syringe100%Part D<11 patientsAnti-infectives
16.1%Azole Antifungal7.2%Ketoconazole100%Part D≥31 patientsSulfone5.2%Dapsone100%Part D<11 patients+ 2 more classes in this area
Antiparasitic
14.9%Antimalarial14.9%Hydroxychloroquine Sulfate100%Part D≥17 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Eosinophilic Fasciitis: New Developments and Future Directions
International Journal of Dermatology
2025 - Eruptive dysplastic melanocytic nevi induced by setmelanotide
International Journal of Dermatology
2025 - Impact of morbilliform drug eruptions on health-related quality of life: a qualitative analysis
British Journal of Dermatology
2025 - Validation of the EuroSCAR criteria for acute generalized exanthematous pustulosis: A retrospective cohort study
Journal of the American Academy of Dermatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”